MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

INTRODUCTION: After deep vein thrombosis, up to 50% of patients develop post-thrombotic syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL). Cornerstones of PTS treatment include the use of elastic compression stockings but this treatment is usually incompletely effective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Galanaud, Jean Philippe, Abdulrehman, Jameel, Lazo-Langner, A, Le Gal, Grégoire, Shivakumar, Sudeep, Schulman, Sam, Kahn, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438950/
https://www.ncbi.nlm.nih.gov/pubmed/34518263
http://dx.doi.org/10.1136/bmjopen-2021-049557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438950/
https://www.ncbi.nlm.nih.gov/pubmed/34518263
http://dx.doi.org/10.1136/bmjopen-2021-049557

Ejemplares similares